Coronavirus Makes CBD Stock Outlook For 2020 Extremely Volatile For The Short Term


All those predictions for the CBD market hitting $2.1 billion in 2020 by hemp business publications may have been right earlier, but the coronavirus and its global impact has changed everything. CBD may still be a growth and consolidation industry, but the coronavirus has changed daily activities of consumers and brick-and-mortar retail businesses so projecting CBD stock outlook for 2020 is more than an art — it’s really a guess. Coronavirus makes CBD stock outlook for 2020 extremely volatile for the short term. The market is gaining and losing 1,000+ points daily.

The impact of the coronavirus globally has intensified coverage of CBD. Companies such as feature coverage of CBD related stocks such as CBD Unlimited, Inc. (OTC PINK: EDXC), Canopy Growth Corp. (NYSE: CGC), New Age Beverages Corp. (NASDAQ: NBEV), GW Pharmaceuticals PLC (NASDAQ: GWPH), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT).  Aurora Cannabis Inc. (NYSE:ACB) and OrganiGram Holdings Inc. (NASDAQ: OGI).

Coronavirus Makes CBD Stock Outlook For 2020 Extremely Volatile For The Short Term

At least for the next few months, predicting CBD stock performance will be more than difficult — it will be near impossible. No travelers will come to the U.S. from many foreign  countries, small businesses may struggle but have SBA low-interest loans to help, large sports and music events will be canceled. In short, American consumers will hunker down. With 70% of CBD sales made on the internet, there is good news for the industry. But for brick-and-mortar CBD shops in malls, strip centers and in remote locations, making CBD sales may be more difficult in-person  in the months ahead due to a dearth of foot traffic. Coronavirus makes CBD stock outlook for 2020 extremely volatile for the short term.

Prior to the start of 2020, analysts were primarily concerned about product legalization in the new year. Now, it’s a matter in CBD of remaining aggressive, being active in M&A and extending product lines to attract the consumer. Branding is important and product quality in CBD is especially important now as the coronavirus has made consumers extra-aware of the food brands they buy. Branding is also a key factor to CBD companies in making 2020 a growth year.

CBD Unlimited, Inc. (OTC PINK: EDXC) Is Positioned To Expand

Despite the wholesale changes in daily living patterns due to the spreading coronavirus, CBD Unlimited, Inc. (OTC PINK: EDXC) is still reporting high organic sales gains and remains active in M&A activity as it seeks to expand product lines within the category. Companies like CBD Unlimited, Inc. (OTC PINK: EDXC) will continue to build their high profile and brand status within the financial community as well as the CBD market. Coronavirus will have changed numerous travel plans for business influencers and consumer buyers alike, but companies like CBD Unlimited, Inc. (OTC PINK: EDXC) will continue to be aggressive in buying other companies and marketing to retailers.

Last week, CBD Unlimited, Inc., acquired Kush, Inc., a New York-based media driven entity that builds brands and also owns It expands the lines of CBD Unlimited, Inc. (OTC PINK: EDXC) and positions the company to extend its product pipeline into clothing brands under the Kushwear name. It has also hired full time Charlie Mohr, president and founder of Kush, Inc., who will now work a new wholly-owned subsidiary of CBD Unlimited, Inc. (OTC PINK: EDXC). Todd Davis, CEO and chairman of CBD Unlimited, said the company plans to expand its network. In 2019, CBD Unlimited, Inc. (OTC PINK: EDXC) reported a 101% annual increase in revenues over the prior year. Davis said the company is ‘on track’ to meet its upward growth trajectory and surpass YOY guidance and goals.

CBD Unlimited, Inc.’s  (OTC PINK: EDXC) Strategy To Focus On CBD Product Quality

CBD Unlimited, Inc. (OTC PINK: EDXC) makes sure its CBD products are highest quality, American-manufactured and tightly controlled by a seed-to-shelf strategy. Its hemp is certified and grown in Colorado and Kentucky. It has premium genetics and superior quality, the company said in its recent Corporate Presentation. Its extracts in processing are rich in phyto-cannabinoids and terpenoids which are non-psychoactive. Product is cGMP Certified (Good Manufacturing Practice Certification).

Source: Stock Market Press

Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.

Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.


Stock Market Press
110 Wall St.
New York, NY 10005 Safe Harbor Statement:

Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

See Stock Market Press disclaimer: SOURCE: Stock Market Press